New Tool: ProSource
Check out our packaging and processing solutions finder, ProSource.

Pfizer Recalls All Chantix Nationwide

The recall is a precautionary measure taken after the medicine was found to contain a cancer-causing impurity.

Earlier this summer, Pfizer halted global distribution of its smoking cessation drug, Chantix. A few weeks later, the company recalled over a dozen lots of the drug. Now, according to a Fierce Pharma article, the drugmaker is recalling all 0.5 mg and 1 mg lots across the country. The reason is the the drug was found to contain unacceptable levels of a specific nitrosamine, which can cause cancer over time with exposure to high levels. The drug was approved by the FDA 15 years ago, and saw nearly a billion in sales last year.

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Read More
Discover Our Content Hub
How to Honor a Leader
Induction into the Packaging & Processing Hall of Fame is the highest honor in our industry. Submit your leader to be considered for the Class of 2024 now through June 10th. New members will be inducted at PACK EXPO International in Chicago.
Read More
How to Honor a Leader